HRTX
NASDAQ
$0.48
Heron Therapeutics Inc (HRTX)
Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $2 (+316.32%)
Market Cap
$83M
Free Cash Flow Yield
-25.06%
Beta (5Y)
1.23
Price Chart
Valuation
Market Cap$83M
Forward P/E46.95
P/S0.54
P/B9.76
Profitability
Total Revenue (TTM)$151M
Gross Profit (TTM)$95M
EBITDA-$8.16M
Profit Margin-23.4%
Operating Margin-13.7%
EPS-$0.14
Financial Health
Free Cash Flow Yield-25.06%
Growth & Risk
Revenue 5Y CAGR+12.60%
FCF 5Y CAGR-36.27%
Beta (5Y)1.23
Sharpe Ratio-1.28